13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 30 holding rows worth $102,791,176.
- Accession
- 0000950123-23-002336
- Filer
- CIK 1822947
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 30 entries on the cover page, a total value of $102,791,176 stated on the cover page (in dollars after the unit check, H1), rows summing to $102,791,176 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 185,261 | $8,583,142 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 632,997 | $8,121,352 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 474,741 | $7,557,877 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,191,271 | $6,980,848 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 140,054 | $6,215,597 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 622,364 | $5,240,305 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 37,639 | $4,836,988 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 962,694 | $4,630,558 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 119,008 | $4,538,965 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 3,730,859 | $4,514,339 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 326,428 | $4,044,443 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 1,015,273 | $4,010,328 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 142,002 | $3,710,512 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 868,403 | $3,117,567 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 896,618 | $3,048,501 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,334,661 | $3,016,334 | dollars as filed | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 2,558,474 | $2,891,076 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 179,085 | $2,485,700 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 125,176 | $2,449,694 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 47,520 | $2,153,131 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 12,180 | $2,062,196 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 811,555 | $2,045,119 | dollars as filed | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 5,894,897 | $1,767,290 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 630,584 | $1,500,790 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 405,602 | $1,452,055 | dollars as filed | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 699,664 | $790,620 | dollars as filed | |
| CURIS INC | 231269200 | COM | 827,397 | $455,068 | dollars as filed | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 159,232 | $286,618 | dollars as filed | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 384,397 | $159,602 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 4,479 | $124,561 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-002336 | this filing | 2023-02-14 | acceptance time not in the bulk data set |